Vanguard Group »

Intellia Therapeutics shares owned by Vanguard Group

Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by Vanguard Group from 13F filings

Historical chart of Vanguard Group investment in Intellia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Intellia Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intellia Therapeutics by Vanguard Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $255M 8.3M 30.49
2023-09-30 $259M 8.2M 31.62
2023-06-30 $334M 8.2M 40.78
2023-03-31 $303M 8.1M 37.27
2022-12-31 $273M 7.8M 34.89
2022-06-30 $337M 6.5M 51.76
2022-03-31 $465M 6.4M 72.67
2021-09-30 $852M 6.4M 134.15
2021-06-30 $976M 6.0M 161.91
2021-03-31 $448M 5.6M 80.26
2020-12-31 $279M 5.1M 54.40
2020-09-30 $87M 4.4M 19.88
2020-06-30 $90M 4.3M 21.02
2020-03-31 $43M 3.5M 12.23
2019-12-31 $52M 3.5M 14.67
2019-09-30 $47M 3.5M 13.70
2019-03-31 $48M 2.8M 17.08
2018-12-31 $38M 2.7M 13.70
2018-09-30 $76M 2.7M 28.63
2018-06-30 $65M 2.4M 27.36
2018-03-31 $42M 2.0M 21.12
2017-12-31 $35M 1.8M 19.20
2017-09-30 $26M 1.0M 24.86
2017-06-30 $16M 997k 16.01
2017-03-31 $13M 905k 14.05
2016-12-31 $12M 871k 13.15
2016-09-30 $7.5M 440k 17.06
2016-06-30 $8.9M 417k 21.37